chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Arm was itchy at the injection site; Arm was red at the injection site; Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Arm was itchy at the injection site), VACCINATION SITE ERYTHEMA (Arm was red at the injection site) and VACCINATION SITE PAIN (Sore) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Arm was itchy at the injection site), VACCINATION SITE ERYTHEMA (Arm was red at the injection site) and VACCINATION SITE PAIN (Sore). At the time of the report, VACCINATION SITE PRURITUS (Arm was itchy at the injection site), VACCINATION SITE ERYTHEMA (Arm was red at the injection site) and VACCINATION SITE PAIN (Sore) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications not reported Treatment medications were not provided
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ear ringing bilaterally/soft ringing; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Mar-2021 and was forwarded to Moderna on 12-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ear ringing bilaterally/soft ringing) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ear ringing bilaterally/soft ringing). At the time of the report, TINNITUS (Ear ringing bilaterally/soft ringing) outcome was unknown.            No relevant concomitant medications were reported.  The patient noticed ear ringing bilaterally 3 weeks before this report. Soft ringing, only heard when all else was quite. The patient went to ear, nose, throat specialist  (ENT) and was told she had healthy ears. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: No new information
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Vaccination failure, Vaccination site erythema, Vaccination site swelling
Clinical narrative: I started thinking the vaccine went to my skin and now it is not effective; Arm was all red all the way down almost to my elbow, very long part of my arm, it was very red; It was very long part of my arm, was very red and swollen; The 1 inch needle goes into my skin and not my muscle; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Arm was all red all the way down almost to my elbow, very long part of my arm, it was very red), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The 1 inch needle goes into my skin and not my muscle), PERIPHERAL SWELLING (It was very long part of my arm, was very red and swollen) and VACCINATION FAILURE (I started thinking the vaccine went to my skin and now it is not effective) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 11-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The 1 inch needle goes into my skin and not my muscle). On 12-Feb-2021, the patient experienced ERYTHEMA (Arm was all red all the way down almost to my elbow, very long part of my arm, it was very red) and PERIPHERAL SWELLING (It was very long part of my arm, was very red and swollen). 12-Feb-2021, the patient experienced VACCINATION FAILURE (I started thinking the vaccine went to my skin and now it is not effective). On 11-Feb-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The 1 inch needle goes into my skin and not my muscle) had resolved. At the time of the report, ERYTHEMA (Arm was all red all the way down almost to my elbow, very long part of my arm, it was very red), PERIPHERAL SWELLING (It was very long part of my arm, was very red and swollen) and VACCINATION FAILURE (I started thinking the vaccine went to my skin and now it is not effective) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was unknown. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events (vaccination site erythema and vaccination site swelling) a causal relationship cannot be excluded. Based on the information reported, the second dose was still pending, so the event (vaccination failure) is assessed as unlikely related to mRNA-1273. This report refers to a case of underdose, and device connection team for mRNA-1273, lot # 041L20A with no associated AEs.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and LNPSF100MCG) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy (He has lung cancer and goes to Chemotherapy twice a month.) since an unknown date. Concurrent medical conditions included Lung cancer. Concomitant products included INSULIN and METFORMIN for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PRURITUS (Itchiness). At the time of the report, PRURITUS (Itchiness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up information included patient demographics, historical condition, second dose suspect drug details, event information was updated.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Migraine; Felt tired; Notice red bumps that were warm and itchy on the same site as the injection site; Notice red bumps that were warm and itchy on the same site as the injection site; Notice red bumps that were warm and itchy on the same site as the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Notice red bumps that were warm and itchy on the same site as the injection site), MIGRAINE (Migraine), VACCINATION SITE PRURITUS (Notice red bumps that were warm and itchy on the same site as the injection site), FATIGUE (Felt tired) and VACCINATION SITE ERYTHEMA (Notice red bumps that were warm and itchy on the same site as the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  .  Concomitant products included APIXABAN (ELIQUIS), METOPROLOL and PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Notice red bumps that were warm and itchy on the same site as the injection site), VACCINATION SITE PRURITUS (Notice red bumps that were warm and itchy on the same site as the injection site) and VACCINATION SITE ERYTHEMA (Notice red bumps that were warm and itchy on the same site as the injection site). On an unknown date, the patient experienced MIGRAINE (Migraine) and FATIGUE (Felt tired). At the time of the report, VACCINATION SITE WARMTH (Notice red bumps that were warm and itchy on the same site as the injection site), MIGRAINE (Migraine), VACCINATION SITE PRURITUS (Notice red bumps that were warm and itchy on the same site as the injection site), FATIGUE (Felt tired) and VACCINATION SITE ERYTHEMA (Notice red bumps that were warm and itchy on the same site as the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Dizziness, Fatigue, Feeling abnormal, Headache
Clinical narrative: Tingling pressure in the head; Brain fog; Difficulty with word finding; Lightheaded/ dizzy; Headache, head pressure; Fatigue low energy; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling pressure in the head), FEELING ABNORMAL (Brain fog), APHASIA (Difficulty with word finding), DIZZINESS (Lightheaded/ dizzy) and HEADACHE (Headache, head pressure) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Egg allergy (Egg sensitivity). Concomitant products included ZINC, WITHANIA SOMNIFERA (ASHWAGANDHA [WITHANIA SOMNIFERA]), VITAMIN B COMPLEX (B COMPLEX (B50)) and MAGNESIUM for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PARAESTHESIA (Tingling pressure in the head), FEELING ABNORMAL (Brain fog), APHASIA (Difficulty with word finding), DIZZINESS (Lightheaded/ dizzy), HEADACHE (Headache, head pressure) and FATIGUE (Fatigue low energy). On 17-Mar-2021, PARAESTHESIA (Tingling pressure in the head), FEELING ABNORMAL (Brain fog), APHASIA (Difficulty with word finding), DIZZINESS (Lightheaded/ dizzy), HEADACHE (Headache, head pressure) and FATIGUE (Fatigue low energy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow - up was received on 22-Jun-2021 contain significant information.New reporter was added, updates of patient demographics, medical history and added Concomitant medications, vaccine batch/lot number, Outcome of the events unknown to recovered /resolved.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling pressure in the head; Brain fog; Difficulty with word finding; Lightheaded/ dizzy; Headache, head pressure; Fatigue low energy; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling pressure in the head), FEELING ABNORMAL (Brain fog), APHASIA (Difficulty with word finding), DIZZINESS (Lightheaded/ dizzy) and HEADACHE (Headache, head pressure) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Egg allergy (Egg sensitivity). Concomitant products included ZINC, WITHANIA SOMNIFERA (ASHWAGANDHA [WITHANIA SOMNIFERA]), VITAMIN B COMPLEX (B COMPLEX (B50)) and MAGNESIUM for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PARAESTHESIA (Tingling pressure in the head), FEELING ABNORMAL (Brain fog), APHASIA (Difficulty with word finding), DIZZINESS (Lightheaded/ dizzy), HEADACHE (Headache, head pressure) and FATIGUE (Fatigue low energy). On 17-Mar-2021, PARAESTHESIA (Tingling pressure in the head), FEELING ABNORMAL (Brain fog), APHASIA (Difficulty with word finding), DIZZINESS (Lightheaded/ dizzy), HEADACHE (Headache, head pressure) and FATIGUE (Fatigue low energy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow - up was received on 22-Jun-2021 contain significant information.New reporter was added, updates of patient demographics, medical history and added Concomitant medications, vaccine batch/lot number, Outcome of the events unknown to recovered /resolved.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Pain in extremity, Pyrexia
Clinical narrative: arm pain; diarrhea; chills; 100.3 temperature; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), DIARRHOEA (diarrhea), CHILLS (chills) and PYREXIA (100.3 temperature) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), DIARRHOEA (diarrhea), CHILLS (chills) and PYREXIA (100.3 temperature). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form and BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (arm pain), DIARRHOEA (diarrhea), CHILLS (chills) and PYREXIA (100.3 temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100.3 (High) 100.3 degree Fahrenheit.         No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Additional information received captured reporter contact details.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Hypoaesthesia, Peripheral swelling, Pruritus, Rash
Clinical narrative: Arm has swollen; Arm numb on the side; Arm itching really bad; Rash on arm; Arm redness; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA (Arm redness), PERIPHERAL SWELLING (Arm has swollen), HYPOAESTHESIA (Arm numb on the side), PRURITUS (Arm itching really bad) and RASH (Rash on arm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ERYTHEMA (Arm redness). On 07-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm has swollen), HYPOAESTHESIA (Arm numb on the side), PRURITUS (Arm itching really bad) and RASH (Rash on arm). At the time of the report, ERYTHEMA (Arm redness), PERIPHERAL SWELLING (Arm has swollen), HYPOAESTHESIA (Arm numb on the side), PRURITUS (Arm itching really bad) and RASH (Rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment details included anti-histaminics and a hydrocortisone cream  with ice all day.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Incorrect dose administered
Clinical narrative: Concomitant products included USTEKINUMAB (STELARA) for an unknown indication.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Received two 0.5ML doses of the Moderna COVID-19 vaccine the same day) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received two 0.5ML doses of the Moderna COVID-19 vaccine the same day). On 11-Mar-2021, INCORRECT DOSE ADMINISTERED (Received two 0.5ML doses of the Moderna COVID-19 vaccine the same day) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received two 0.5ML doses of the Moderna COVID-19 vaccine the same day) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Dysphonia, Hypersensitivity, Peripheral swelling, Pharyngeal swelling
Clinical narrative: Allergic reaction; Face and throat became swollen; Face and throat became swollen; Unable to swallow normally; Swollen fingers; Voice has been affected; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), SWELLING FACE (Face and throat became swollen), PHARYNGEAL SWELLING (Face and throat became swollen), DYSPHAGIA (Unable to swallow normally) and PERIPHERAL SWELLING (Swollen fingers) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HYPERSENSITIVITY (Allergic reaction), SWELLING FACE (Face and throat became swollen), PHARYNGEAL SWELLING (Face and throat became swollen), DYSPHAGIA (Unable to swallow normally), PERIPHERAL SWELLING (Swollen fingers) and DYSPHONIA (Voice has been affected). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Allergic reaction), SWELLING FACE (Face and throat became swollen), PHARYNGEAL SWELLING (Face and throat became swollen), DYSPHAGIA (Unable to swallow normally), PERIPHERAL SWELLING (Swollen fingers) and DYSPHONIA (Voice has been affected) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided. Treatment for the events included diphenhydramine hydrochloride which helped ease the symptoms and the symptoms started to resolve in approximately four to five days.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Allergic reaction; Face and throat became swollen; Face and throat became swollen; Unable to swallow normally; Swollen fingers; Voice has been affected; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), SWELLING FACE (Face and throat became swollen), PHARYNGEAL SWELLING (Face and throat became swollen), DYSPHAGIA (Unable to swallow normally) and PERIPHERAL SWELLING (Swollen fingers) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HYPERSENSITIVITY (Allergic reaction), SWELLING FACE (Face and throat became swollen), PHARYNGEAL SWELLING (Face and throat became swollen), DYSPHAGIA (Unable to swallow normally), PERIPHERAL SWELLING (Swollen fingers) and DYSPHONIA (Voice has been affected). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Allergic reaction), SWELLING FACE (Face and throat became swollen), PHARYNGEAL SWELLING (Face and throat became swollen), DYSPHAGIA (Unable to swallow normally), PERIPHERAL SWELLING (Swollen fingers) and DYSPHONIA (Voice has been affected) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided. Treatment for the events included diphenhydramine hydrochloride which helped ease the symptoms and the symptoms started to resolve in approximately four to five days.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache; Back muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and MYALGIA (Back muscle pain) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache) and MYALGIA (Back muscle pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and SULFAMETHOXAZOLE, TRIMETHOPRIM (MORTIN) at an unspecified dose and frequency. On 11-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, MYALGIA (Back muscle pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Mobility decreased
Clinical narrative: Patient not being able to sit up or stand; Chest pains; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pains) and MOBILITY DECREASED (Patient not being able to sit up or stand) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced CHEST PAIN (Chest pains). On 12-Mar-2021, the patient experienced MOBILITY DECREASED (Patient not being able to sit up or stand). At the time of the report, CHEST PAIN (Chest pains) and MOBILITY DECREASED (Patient not being able to sit up or stand) outcome was unknown.            No relevant concomitant medications were reported.  It was reported that on 12-MAR-2021, patient had chest pain that became unbearable lasting for 20 minutes, restoring to the patient not able to sit or stand. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypoaesthesia
Clinical narrative: Left arm went numb to her elbow, numb to palm of hand; Neck and back around shoulder blade was feeling weird; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Left arm went numb to her elbow, numb to palm of hand) and FEELING ABNORMAL (Neck and back around shoulder blade was feeling weird) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced HYPOAESTHESIA (Left arm went numb to her elbow, numb to palm of hand) and FEELING ABNORMAL (Neck and back around shoulder blade was feeling weird). On 11-Mar-2021, HYPOAESTHESIA (Left arm went numb to her elbow, numb to palm of hand) and FEELING ABNORMAL (Neck and back around shoulder blade was feeling weird) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   20 minutes after receiving vaccine patient's left arm went numb to her elbow.  About 10 minutes after her palm of hand was numb. 5 to 10 minutes later her neck and back around shoulder blade started feeling weird. 5 to 10 minutes, left side of her face felt numb. By the time she got home the reaction started to go away except for her face. The patient went to emergency room (ER) and they called it a vaccine reaction. On 12-MAR-2021, patient left side of her face was slightly numb. All the numbness was on her left side.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Pain, Pain in extremity
Clinical narrative: Super cold; Achy; Tired; Chills; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Super cold), PAIN (Achy), PAIN IN EXTREMITY (Sore Arm), FATIGUE (Tired) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 12-Mar-2021, the patient experienced FEELING COLD (Super cold), PAIN (Achy), FATIGUE (Tired) and CHILLS (Chills). At the time of the report, FEELING COLD (Super cold), PAIN (Achy), PAIN IN EXTREMITY (Sore Arm), FATIGUE (Tired) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Muscle spasms, Myalgia, Nausea
Clinical narrative: Spasm on both sides of her rib cage; Her whole trunk was achy; Fever; Nausea; Headache; Joint pain; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Spasm on both sides of her rib cage), PAIN (Her whole trunk was achy), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (Her whole trunk was achy), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On an unknown date, the patient experienced MUSCLE SPASMS (Spasm on both sides of her rib cage). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Spasm on both sides of her rib cage) outcome was unknown and PAIN (Her whole trunk was achy), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain) was resolving.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Spasm on both sides of her rib cage; Her whole trunk was achy; Fever; Nausea; Headache; Joint pain; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Spasm on both sides of her rib cage), PAIN (Her whole trunk was achy), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (Her whole trunk was achy), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On an unknown date, the patient experienced MUSCLE SPASMS (Spasm on both sides of her rib cage). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Spasm on both sides of her rib cage) outcome was unknown and PAIN (Her whole trunk was achy), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain) was resolving.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Vision blurred
Clinical narrative: Blurry vision for 3-4 minutes immediately after receiving the dose; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision for 3-4 minutes immediately after receiving the dose), CHILLS (chills) and PYREXIA (fever) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VISION BLURRED (Blurry vision for 3-4 minutes immediately after receiving the dose), CHILLS (chills) and PYREXIA (fever). The patient was treated with IBUPROFEN on 12-Mar-2021 at a dose of 1 dosage form. On 11-Mar-2021, VISION BLURRED (Blurry vision for 3-4 minutes immediately after receiving the dose) had resolved. At the time of the report, CHILLS (chills) and PYREXIA (fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 102 (High) Fever of 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: administered a dose to a 16 year old not knowing the age restriction of 18; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered a dose to a 16 year old not knowing the age restriction of 18) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered a dose to a 16 year old not knowing the age restriction of 18). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered a dose to a 16 year old not knowing the age restriction of 18) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was reported. No concomitant medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: No new information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Cough, Nausea, Vaccination site pain
Clinical narrative: feeling weak; cough; nausea; Soreness of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling weak), COUGH (cough), NAUSEA (nausea) and VACCINATION SITE PAIN (Soreness of the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feeling weak), COUGH (cough), NAUSEA (nausea) and VACCINATION SITE PAIN (Soreness of the injection site). At the time of the report, ASTHENIA (feeling weak), COUGH (cough), NAUSEA (nausea) and VACCINATION SITE PAIN (Soreness of the injection site) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medication was reported.  It was not reported if the patient was received any corrective treatment for the event.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder, Headache, Hypoaesthesia, Migraine, Pain
Clinical narrative: left arm down to her hand feels like pinprick and numbness; left arm down to her hand feels like pinprick and numbness; semi pain; Feels like a migraine; intense headache; Headache has her eyes "jacked up"; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (Headache has her eyes "jacked up"), PARAESTHESIA (left arm down to her hand feels like pinprick and numbness), HYPOAESTHESIA (left arm down to her hand feels like pinprick and numbness), PAIN (semi pain) and MIGRAINE (Feels like a migraine) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EYE DISORDER (Headache has her eyes "jacked up"), MIGRAINE (Feels like a migraine) and HEADACHE (intense headache). On 11-Mar-2021, the patient experienced PARAESTHESIA (left arm down to her hand feels like pinprick and numbness), HYPOAESTHESIA (left arm down to her hand feels like pinprick and numbness) and PAIN (semi pain). At the time of the report, EYE DISORDER (Headache has her eyes "jacked up"), PARAESTHESIA (left arm down to her hand feels like pinprick and numbness), HYPOAESTHESIA (left arm down to her hand feels like pinprick and numbness), PAIN (semi pain), MIGRAINE (Feels like a migraine) and HEADACHE (intense headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment details were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: left arm down to her hand feels like pinprick and numbness; left arm down to her hand feels like pinprick and numbness; semi pain; Feels like a migraine; intense headache; Headache has her eyes "jacked up"; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (Headache has her eyes "jacked up"), PARAESTHESIA (left arm down to her hand feels like pinprick and numbness), HYPOAESTHESIA (left arm down to her hand feels like pinprick and numbness), PAIN (semi pain) and MIGRAINE (Feels like a migraine) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EYE DISORDER (Headache has her eyes "jacked up"), MIGRAINE (Feels like a migraine) and HEADACHE (intense headache). On 11-Mar-2021, the patient experienced PARAESTHESIA (left arm down to her hand feels like pinprick and numbness), HYPOAESTHESIA (left arm down to her hand feels like pinprick and numbness) and PAIN (semi pain). At the time of the report, EYE DISORDER (Headache has her eyes "jacked up"), PARAESTHESIA (left arm down to her hand feels like pinprick and numbness), HYPOAESTHESIA (left arm down to her hand feels like pinprick and numbness), PAIN (semi pain), MIGRAINE (Feels like a migraine) and HEADACHE (intense headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment details were reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Palpitations
Clinical narrative: woke up to a fast heart rate; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (woke up to a fast heart rate) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PALPITATIONS (woke up to a fast heart rate). At the time of the report, PALPITATIONS (woke up to a fast heart rate) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Heart rate: 105 (abnormal) fast heart rate around 105.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 52.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Vaccination complication
Clinical narrative: vaccination adverse reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (vaccination adverse reaction) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) capsule for Chronic lymphocytic leukemia.    No Medical History information was reported.   On 28-Feb-2019, the patient started IBRUTINIB (IMBRUVICA) (Oral) 140 milligram three times a day. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up information  received on 24-May-2021 contains non significant information. Possible NNI. On 28-May-2021: No new information provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: localised rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (localised rash) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) capsule for CLL.    Concurrent medical conditions included Thyroid disorder, Ileostomy and Hypercholesteraemia. Concomitant products included ALENDRONATE SODIUM, ALLOPURINOL, AMLODIPINE BESYLATE, EZETIMIBE, BIOTIN, FOLIC ACID, CHONDROITIN SULFATE, GLUCOSAMINE SULFATE, METHYLSULFONYLMETHANE (GLUCOSAMINE CHONDROITIN & MSM), LEVOTHYROXINE SODIUM, SIMVASTATIN, TEMAZEPAM, MAGNESIUM, THERAWORX RELIEF, TRAMADOL HCL and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and IBRUTINIB (IMBRUVICA) (Oral) 420 mg. On an unknown date, the patient experienced RASH (localised rash). At the time of the report, RASH (localised rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: sore arm; feeling fatigued; arm was increasingly becoming red and hot/bright red; arm was increasingly becoming red and hot; redness and swelling the size of your hand; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA, SKIN WARM, PERIPHERAL SWELLING, PAIN IN EXTREMITY, and FATIGUE in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation. Concomitant products included ELIQUIS, FLECAINIDE, METOPROLOL, ATORVASTATIN, and GABAPENTIN for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced ERYTHEMA, SKIN WARM, PERIPHERAL SWELLING, and FATIGUE. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY. The patient was treated with BENADRYL from 26-Feb-2021 to 27-Feb-2021 at an unspecified dose and frequency. On 26-Feb-2021, FATIGUE outcome was unknown. At the time of the report, ERYTHEMA, SKIN WARM, PERIPHERAL SWELLING, and PAIN IN EXTREMITY outcome was unknown.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Nausea
Clinical narrative: Weak; Feeling tired; Nauseous; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA, HEADACHE, FATIGUE, and NAUSEA in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included LATUDA and PAROXETINE for Depression, CLONAZEPAM for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced HEADACHE. On an unknown date, the patient experienced ASTHENIA, FATIGUE, and NAUSEA. The patient was treated with TYLENOL at an unspecified dose and frequency; NAPROXEN and IBUPROFEN. At the time of the report, ASTHENIA, HEADACHE, FATIGUE, and NAUSEA outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC. MOD-2021-080487 (E2B Linked Report). This case was linked to MOD-2021-080487 (Patient Link). Sender's Comments:  US-MODERNATX, INC. MOD-2021-080487.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Blood cholesterol, Blood glucose, Blood pressure measurement, Eye pain, Headache
Clinical narrative: Pain in left eye; Pain in arm; Headache- front head still hurts; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN, PAIN IN EXTREMITY, and HEADACHE in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for Diabetes.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE PAIN, PAIN IN EXTREMITY, and HEADACHE. The patient was treated with OXYMETAZOLINE HYDROCHLORIDE ongoing since an unknown date for Headache, at an unspecified dose and frequency; TYLENOL for Headache, at an unspecified dose and frequency; IBUPROFEN for Headache, at an unspecified dose and frequency and NAPROXEN for Headache, at an unspecified dose and frequency. At the time of the report, EYE PAIN and PAIN IN EXTREMITY outcome was unknown and HEADACHE had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Blood cholesterol: 160 (normal). On 10-Apr-2021, Blood glucose: 96 (normal). On 10-Apr-2021, Blood pressure measurement (80-120): 157 (High) Hypertension and 126/60 (normal) 126/60. On 10-Apr-2021, Heart rate: increased (High).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was in the ER for 5 hours and was admitted to the hospital because they wanted to perform some tests.  Patient states she went home and still has headache till today. Her front head still hurts.   This case was linked to US-MODERNATX, INC MOD-2021-080351 (E2B Linked Report). This case was linked to MOD-2021-080351.